Moreover, E2 has a low affinity for GPER, unlike some endocrine disruptors, such as bisphenol A or atrazine, which have a high affinity for GPER, as observed in ovarian and breast cancer cells [24,25], and recently in seminoma cells [26]. This evidence concerns the gene GPER1 and breast cancer.